Investigation announced for Investors in Blueprint Medicines Corporation (NASDAQ: BPMC) over possible Violations of Securities Laws | openPR.com - New Public Relations: Business, Economy, Finances, Banking & Insurance
Blueprint Medicines Corporation is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Blueprint Medicines Corporation (NASDAQ: BPMC), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)